Twin study seeks genetic clues to childhood brain cancer
NCT ID NCT06054295
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study is looking at 25 pairs of identical twins where only one twin has a childhood brain tumor. Researchers will collect blood and saliva samples to search for small genetic differences, called somatic mosaicism, that might explain why one twin got sick and the other stayed healthy. The goal is to better understand what causes these tumors, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help explain why some children develop brain tumors while their identical twin does not, pointing toward new ways to understand or predict cancer risk.
- What could go wrong
- This is a very small pilot study with only 50 participants, so findings may not apply to all children. It is designed to gather information, not to test a treatment, so there is no direct benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Glowing dye could help surgeons spot hidden brain tumor cells
- Engineered immune cells target deadly brain tumors in children
- New stem cell transplant aims to cut dangerous side effects in blood cancer patients
- Scientists decode DNA of rare eye tumors to track Cancer's moves
- Gut bacteria linked to cancer survivor symptoms?
- New hope for kids with deadly brain cancer? drug ONC206 enters human trials